Andrew Baxter
Vascular Surgery · Fairfield, CTNPI 1124346481
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,688 of the $10,912 with a category attached, or 61.3%. It is spread thinly across 30 manufacturers, the largest accounting for just 21.6%. 2025 is the largest year on record at $3,095, 2.2 times the $1,438 reported in 2019.
Across 218 payments — averaging $50.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$2K
- Inari Medical, Inc.$2K
- Cook Medical LLC$1K
- Silk Road Medical, Inc.$1K
- Johnson & Johnson$797
- E.r. Squibb & Sons, L.L.C.$754
- plus $3K from 24 others
What the payments were for
- Travel & lodging$1,90717%
- Food & beverage$6,68861%
- Other$2,31721%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 2 | $2,357 |
| Inari Medical, Inc. | 11 | $1,554 |
| Cook Medical LLC | 36 | $1,144 |
| Silk Road Medical, Inc. | 8 | $1,124 |
| Johnson & Johnson | 43 | $797 |
| E.r. Squibb & Sons, L.L.C. | 49 | $754 |
| Medtronic(3 entities) | 10 | $683 |
| Endologix LLC | 5 | $631 |
| Philips North America LLC | 8 | $572 |
| Boston Scientific | 5 | $429 |
| Tactile Systems Technology Inc | 8 | $133 |
| Pfizer | 6 | $121 |
| Cardiovascular Systems Inc. | 3 | $74 |
| Veryan Medical Incorporated | 1 | $59 |
| Smith+Nephew | 3 | $52 |
| Asahi Intecc USA, Inc. | 1 | $50 |
| Penumbra, Inc. | 2 | $47 |
| Lemaitre Vascular, Inc. | 2 | $46 |
| Stryker | 2 | $46 |
| KCI USA, Inc. | 2 | $38 |
| Davol Inc. | 1 | $37 |
| Solventum Corporation | 2 | $28 |
| Abbott | 1 | $25 |
| Teleflex LLC | 1 | $20 |
| Bard Peripheral Vascular, Inc. | 1 | $18 |
| Haemonetics Corporation | 1 | $17 |
| Reprise Biomedical, Inc. | 1 | $16 |
| Biocompatibles, Inc. | 1 | $16 |
| Cordis US CORP. | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$2,317
- ENROUTE Transcarotid Neuroprotection System$1,437
- CT THROMBECTOMY SYSTEM KIT$1,334
- FLOWTRIEVER CATHETER, S$1,334
- ENROUTE Transcarotid Stent System$612
- ENHANCE Transcarotid Peripheral Access Kit$612
- ENROUTE 0.014 Guidewire$612
- PIVOX Oblique Lateral Spinal System$474
- ENROUTE Transcarotid Stent$429
- Alto Abdominal Stent Graft System$425
- Zilver PTX$242
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$240
- ADVANCE$154
- IGT D Service Syst$116
- GENERAL PAIN MANAGEMENT$107
- Lasers$106
- Cook Medical AAA$103
- ROSEN$103
How this compares
$10,912 in reported general payments places this provider in the 60th percentile of 82 vascular surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 55 | $59,198 |
| ClopidogrelClopidogrel Bisulfate | 35 | $510 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $121 | $59,19855 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 82 vascular surgery providers in Connecticut.
Other vascular surgery in Fairfield
- Seth BlattmanFairfield$6K
- Brian KingFairfield$3K
- Uwe FischerNew London$941K
- Paul GagneDarien$766K
- Naiem NassiriNew Haven$348K
- Lee GoldsteinStratford$272K
- Mohiuddin CheemaHartford$228K
- Bauer SumpioNew Haven$205K
- Javairiah FatimaDanbury$152K
- Bart MuhsOld Saybrook$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.